AstraZeneca
About
AstraZeneca is a global, science-led biopharmaceutical company whose medicines are used by millions of patients, and it is part of the Kendall Square life sciences community in Cambridge. Formed in 1999 through the merger of Sweden’s Astra and Britain’s Zeneca, it focuses on discovering, developing and commercializing prescription medicines. Its stated aim is to unlock what science can do for people, society and the planet.
Cell therapy is one of its major research areas. The company is building a pipeline that spans CAR T and TCR T therapies, allogeneic approaches and in vivo cell therapies, with the goal of treating blood cancers, solid tumors, autoimmune conditions and rare diseases. Other research covers the connection between heart failure and kidney function and new approach methodologies developed with partners. Sustainability is also central, with work linking climate and health.
What to Know
- AstraZeneca developed CARESA, a tool that measures the environmental footprint of patient care pathways.
- The company is headquartered in Cambridge, England.
- It maintains a historic archive of past product material for reference.
- AstraZeneca is a member of the Kendall Square Association.
Is this your business?
Claim it to add hours, photos, a description and a spotlight story.